our mission
Pharvaris is a clinical-stage company focused on bringing oral bradykinin B2-receptor antagonists to patients. By targeting this clinically proven therapeutic target¹⁻³ with novel, oral small molecules, the Pharvaris team is advancing new alternatives to injected therapies for all sub-types of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications.
Pharvaris is committed to a strong collaboration, closely partnering with patient organizations as well as experts in the HAE community. Throughout the company, we aim to build trust and ongoing dialogue with all members of the community working with and for those with HAE to support people and their families to build knowledge, awareness, education and further HAE research.
¹ Cicardi M et al N Engl J Med 2010 363 532 541
² Lumry WR et al Ann Allergy Asthma Immunol 2011 107 529 537
³ Maurer M et al Clin Exp Allergy 2022 52 1048 1058
consider all those
impacted by our
Mission and what we do
considering
others
care-fully
Prioritize rigorous,
well-informed
decision making based
on robust critical thinking,
pragmatism and
productive challenge
ensuring rigor
& diversity
of thought
Trust and respect
expertise, experience
and decisions made
leading
with
trust
Have the freedom to
contribute, knowing we
will be listened to, and
recognize everyone has a
responsibility to speak up
contributing
freely
considering others
care-fully
Consider all those impacted by our
Mission and what we do
●
Lead with empathy and consider
implications of our actions on
others
●
It’s always “We” not “I”
●
Create the company around the
right people

ensuring rigor &
diversity of thought
Prioritize rigorous, well-informed
decision making based on robust critical
thinking, pragmatism and productive
challenge
●
Act with professionalism and bring
depth of experience and knowledge
●
Be open-minded and non- judgmental,
encouraging and considering diverse
perspectives, opinions and ideas

leading
with trust
Trust and respect expertise,
experience and decisions made
●
Be comfortable with vulnerability and
committed to being real, authentic and
transparent
●
Know it’s ok to take appropriate risks
and sometimes fail, and when
necessary to ask for help
●
Take ownership, responsibility and
always take the initiative

contributing
freely
Have the freedom to contribute,
knowing we will be listened to, and
recognize everyone has a
responsibility to speak up
●
Be free and expected to think
differently and creatively
●
Have the freedom to work in a way
which enables us to be our best

management team

Berndt Modig
Chief Executive Officer, Director

Morgan Conn, Ph.D.
Chief Business Officer

Annick Deschoolmeester
Chief Human Resources Officer

Jochen Knolle, Ph.D.
Chief Scientific Officer, Chief Operating Officer

Anne Lesage, Ph.D.
Chief Early Development Officer

Peng Lu, M.D., Ph.D.
Chief Medical Officer

Joan Schmidt, J.D.
Chief Legal Officer

Wim Souverijns, Ph.D.
Chief Community Engagement & Commercial Officer

Anna Nijdam
Head of Finance, Principal Accounting Officer